Smith CS, Aerts A, Kita E, Virmond M. Time to define leprosy elimination as zero leprosy transmission? Lancet Infect Dis. 2016;16:398–9.
Article
PubMed
Google Scholar
WHO. Global leprosy update, 2018: moving towards a leprosy-free world. Wkly Epidem Rec. 2019a;2019(94):389–412.
Google Scholar
WHO. Global leprosy (Hansen Disease) update, 2019: time to step-up prevention initiatives. Wkly Epidem Rec. 2019b;2020(95):417–40.
Google Scholar
Smith CS, Aerts A, Saunderson P, Kawuma J, Kita E, Virmond M. Multidrug therapy for leprosy: a game changer on the path to elimination. Lancet Infect Dis. 2017;17:e293–7.
Article
PubMed
Google Scholar
Britton WJ, Lockwood DN. Leprosy. Lancet. 2004;363:1209–19.
Article
PubMed
Google Scholar
WHO. Global leprosy strategy 2016–2020. Accelerating towards a leprosy-free world. Geneva: World Health Organization; 2016a.
Google Scholar
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349–57.
Article
PubMed
Google Scholar
Global Partnership for Zero Leprosy. GPZL reports on research priorities. Lepr Rev. 2019;90:237–89.
Article
Google Scholar
Scollard D. Leprosy research is a necessity. Lepr Rev. 2019;90:232–6.
Article
Google Scholar
Smith WC, Saunderson P. Leprosy. BMJ Clin Evid. 2010;2010:0915.
PubMed
PubMed Central
Google Scholar
Scollard D, Gillis T. International Textbook of Leprosy. 2020. Available from https://internationaltextbookofleprosy.org/. Accessed 22 Oct 2020.
Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–10.
Article
PubMed
PubMed Central
Google Scholar
Khazai Z, Van Brakel W, Essink D, Gillis T, Kasang C, Kuipers P, et al. Reviewing research priorities of the leprosy research initiative (LRI): a stakeholder’s consultation. Lepr Rev. 2019;90:3–30.
Article
Google Scholar
WHO and UNICEF. Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. Geneva: World Health Organization and United Nations Children’s Fund; 2020.
Google Scholar
Barbieri RR, Manta FSN, Moreira SJM, Sales AM, Nery JAC, Nascimento LPR, et al. Quantitative polymerase chain reaction in paucibacillary leprosy diagnosis: a follow-up study. PLoS Negl Trop Dis. 2019;13:e0007147.
Article
PubMed
PubMed Central
Google Scholar
Martinez AN, Talhari C, Moraes MO, Talhari S. PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic. PLoS Negl Trop Dis. 2014;8:e2655.
Article
PubMed
PubMed Central
CAS
Google Scholar
van Hooij A, Fat EMTK, Richardus R, van den Eeden SJF, Wilson L, de Dood CJ, et al. Quantitative lateral flow strip assays as user-friendly tools to detect biomarker profiles for leprosy. Sci Rep. 2016;6:34260.
Article
PubMed
PubMed Central
CAS
Google Scholar
Corstjens P, van Hooij A, Tjon Kon Fat EM, Alam K, Vrolijk LB, Dlamini S, et al. Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection. Clin Biochem. 2019;66:76–82.
Article
CAS
PubMed
Google Scholar
van Hooij A, Tjon Kon Fat EM, van den Eeden SJF, Wilson L, Batista da Silva M, Salgado CG, et al. Field-friendly serological tests for determination of M. leprae-specific antibodies. Sci Rep. 2017;7:8868.
Article
PubMed
CAS
Google Scholar
van Hooij A, Tjon Kon Fat EM, Batista da Silva M, Carvalho Bouth R, Cunha Messias AC, Gobbo AR, et al. Evaluation of immunodiagnostic tests for leprosy in Brazil, China and Ethiopia. Sci Rep. 2018;8:17920.
Article
PubMed
PubMed Central
CAS
Google Scholar
Alami H, Gagnon MP, Fortin JP. Digital health and the challenge of health systems transformation. Mhealth. 2017;3:31.
Article
PubMed
PubMed Central
Google Scholar
Kanthraj GR. Patient-assisted teledermatology practice: what is it? When, where, and how it is applied? Indian J Dermatol Venereol Leprol. 2015;81:136–43.
Article
PubMed
Google Scholar
Mieras LF, Taal AT, Post EB, Ndeve AGZ, van Hees CLM. The development of a mobile application to support peripheral health workers to diagnose and treat people with skin diseases in resource-poor settings. Trop Med Infect Dis. 2018;3:102.
Article
PubMed Central
Google Scholar
van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DN, et al. Early diagnosis of neuropathy in leprosy—comparing diagnostic tests in a large prospective study (the INFIR cohort study). PLoS Negl Trop Dis. 2008;2:e212.
Article
PubMed
PubMed Central
Google Scholar
Ebenso J, Muyiwa LT, Ebenso BE. Self care groups and ulcer prevention in Okegbala. Nigeria Lepr Rev. 2009;80:187–96.
Article
PubMed
Google Scholar
Li J, Mu H, Ke W, Bao X, Wang Y, Wang Z, et al. The sustainability of self-care in two counties of Guizhou Province, Peoples’ Republic of China. Lepr Rev. 2008;79:110–7.
Article
PubMed
Google Scholar
Chandler DJ, Hansen KS, Mahato B, Darlong J, John A, Lockwood DN. Household costs of leprosy reactions (ENL) in rural India. PLoS Negl Trop Dis. 2015;9:e0003431.
Article
PubMed
PubMed Central
CAS
Google Scholar
Blok DJ, de Vlas SJ, Geluk A, Richardus JH. Minimum requirements and optimal testing strategies of a diagnostic test for leprosy as a tool towards zero transmission: a modeling study. PLoS Negl Trop Dis. 2018;12:e0006529.
Article
PubMed
PubMed Central
Google Scholar
Fischer EA, de Vlas SJ, Habbema JD, Richardus JH. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl Trop Dis. 2011;5:e1330.
Article
PubMed
PubMed Central
Google Scholar
Cochi SL, Dowdle WL. The eradication of infectious diseases. Understanding the lessons and advancing experience. In: Cochi S, Dowdle WR, editors. Disease eradication in the 21st century: implications for global health. Cambridge, MA: MIT Press; 2011.
Chapter
Google Scholar
Medley GF, Blok DJ, Crump RE, Hollingsworth TD, Galvani AP, Ndeffo-Mbah ML, et al. Policy lessons from quantitative modeling of leprosy. Clin Infect Dis. 2018;66:S281–5.
Article
PubMed
PubMed Central
Google Scholar
Blok DJ, de Vlas SJ, Fischer EA, Richardus JH. Mathematical modelling of leprosy and its control. Adv Parasitol. 2015;87:33–51.
Article
PubMed
Google Scholar
Tiwari A, Richardus JH. Investment case concepts in leprosy elimination: a systematic review. Lepr Rev. 2016;87:2–22.
PubMed
Google Scholar
Thompson K, Rabinovich R, Conteh L, Emerson C, Hall B. Group report: developing an eradication investment case. In: Cochi S, Dowdle WR, editors. Disease eradication in the 21st century: implications for global health. Cambridge, MA: MIT Press; 2011. p. 133–48.
Chapter
Google Scholar
Kiefer S, Knoblauch AM, Steinmann P, Barth-Jaeggi T, Vahedi M, Maher D, et al. Operational and implementation research within Global Fund to Fight AIDS, Tuberculosis and Malaria grants: a situation analysis in six countries. Glob Health. 2017;13:22.
Article
Google Scholar
Simpson H, Quao B, van der Grinten E, Saunderson P, Ampadu E, Kwakye-Maclean C, et al. Routine surveillance data as a resource for planning integration of NTD case management. Lepr Rev. 2018;89:178–96.
Article
Google Scholar
Bakker MI, Scheelbeek PFD, van Beers S. The use of GIS in leprosy control. Lepr Rev. 2009;80:327–31.
Article
PubMed
Google Scholar
Penna ML, Wand-Del-Rey-de-Oliveira ML, Penna G. Spatial distribution of leprosy in the Amazon region of Brazil. Emerg Infect Dis. 2009;15:650–2.
Article
PubMed
PubMed Central
Google Scholar
Alencar CH, Ramos AN Jr, dos Santos ES, Richter J, Heukelbach J. Clusters of leprosy transmission and of late diagnosis in a highly endemic area in Brazil: focus on different spatial analysis approaches. Trop Med Int Health. 2012;17:518–25.
Article
PubMed
Google Scholar
Raju MS, John AS, Kuipers P. What stops people completing multi-drug therapy? Ranked perspectives of people with leprosy, their head of family and neighbours—across four Indian states. Lepr Rev. 2015;86:6–20.
Article
CAS
PubMed
Google Scholar
Yotsu RR. Integrated management of Skin NTDs—lessons learned from existing practice and field research. Trop Med Infect Dis. 2018;3:120.
Article
PubMed Central
Google Scholar
Price VG. Factors preventing early case detection for women affected by leprosy: a review of the literature. Glob Health Action. 2017;10:1360550.
Article
PubMed
PubMed Central
Google Scholar
Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11:353–63.
Article
PubMed
Google Scholar
Weiss MG, Doongaji DR, Siddhartha S, Wypij D, Pathare S, Bhatawdekar M, et al. The Explanatory Model Interview Catalogue (EMIC). Contribution to cross-cultural research methods from a study of leprosy and mental health. Br J Psychiatry. 1992;160:819–30.
Article
CAS
PubMed
Google Scholar
Stevelink SA, van Brakel WH. The cross-cultural equivalence of participation instruments: a systematic review. Disabil Rehabil. 2013;35:1256–68.
Article
CAS
PubMed
Google Scholar
Reveiz L, Buendia JA, Tellez D. Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis. Rev Panam Salud Publica. 2009;26:341–9.
Article
PubMed
Google Scholar
Richardus JH. Chemoprophylaxis: sufficient evidence for starting implementation pilots. Lepr Rev. 2015;86:128–9.
Article
PubMed
Google Scholar
Smith WC. Chemoprophylaxis in the prevention of leprosy. BMJ. 2008;336:730–1.
Article
PubMed
PubMed Central
Google Scholar
Moet FJ, Pahan D, Oskam L, Richardus JH, COLEP Study Group. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;336:761–4.
Article
Google Scholar
Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel W, Richardus JH, Tiwari A, et al. Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin. BMJ Open. 2016;6:e013633.
Article
PubMed
PubMed Central
Google Scholar
Steinmann P, Cavaliero A, Aerts A, Anand S, Arif M, Ay SS, et al. The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis. Lepr Rev. 2018;89:102–16.
Article
Google Scholar
Cavaliero A, Greter H, Fürst T, Lay S, Ay SS, Robijn J, et al. An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia. PLoS Negl Trop Dis. 2019;13:e0007039.
Article
PubMed
PubMed Central
Google Scholar
Peters R, Mieras L, Subedi M, Apte H, Koesbardiati T, Banstola NL, et al. A single dose of rifampicin to prevent leprosy: qualitative analysis of perceptions of persons affected, contacts, community members and health professionals towards chemoprophylaxis and the impact on their attitudes in India, Nepal and Indonesia. Lepr Rev. 2018;89:335–52.
Article
Google Scholar
Mieras L, Anthony R, van Brakel W, Bratschi MW, van den Broek J, Cambau E, et al. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy. Infect Dis Poverty. 2016. https://doi.org/10.1186/s40249-016-0140-y.
Article
PubMed
PubMed Central
Google Scholar
Richardus RA, Alam K, Pahan D, Feenstra SG, Geluk A, Richardus JH. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). BMC Infect Dis. 2013;13:456.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mieras LF, Taal AT, van Brakel WH, Cambau E, Saunderson PR, Smith WCS, et al. An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++. BMC Infect Dis. 2018;18:506.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis. 2006;193:346–53.
Article
PubMed
Google Scholar
Mensah-Awere D, Bratschi MW, Steinmann P, Fairley JK, Gillis TP. Symposium report: developing strategies to block the transmission of leprosy. Lepr Rev. 2015;86:156–64.
Article
PubMed
Google Scholar
Merle CS, Cunha SS, Rodrigues LC. BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines. 2010;9:209–22.
Article
CAS
PubMed
Google Scholar
Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I, Maroja Mde F, et al. BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial. PLoS Negl Trop Dis. 2008;2:e167.
Article
PubMed
PubMed Central
CAS
Google Scholar
Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet. 1996;348:17–24.
Article
CAS
Google Scholar
Sharma P, Mukherjee R, Talwar GP, Sarathchandra KG, Walia R, Parida SK, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8–10 years. Lepr Rev. 2005;76:127–43.
Article
PubMed
Google Scholar
Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa, Balasubramanyam S, et al. Comparative leprosy vaccine trial in south India. Indian J Lepr. 1998;70:369–88.
PubMed
Google Scholar
Talwar GP, Gupta JC, Mustafa AS, Kar HK, Katoch K, Parida SK, et al. Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties. Biologics. 2017;11:55–63.
CAS
PubMed
PubMed Central
Google Scholar
Duthie MS, Balagon MF. Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy. Risk Manag Healthc Policy. 2016;9:43–53.
Article
PubMed
PubMed Central
Google Scholar
Schuring RP, Richardus JH, Pahan D, Oskam L. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine. 2009;27:7125–8.
Article
CAS
PubMed
Google Scholar
Duthie MS, Pena MT, Ebenezer GJ, Gillis TP, Sharma R, Cunningham K, et al. LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection. NPJ Vaccines. 2018;3:12.
Article
PubMed
PubMed Central
CAS
Google Scholar
Smith WC, van Brakel W, Gillis T, Saunderson P, Richardus JH. The missing millions: a threat to the elimination of leprosy. PLoS Negl Trop Dis. 2015;9:e0003658.
Article
PubMed
PubMed Central
CAS
Google Scholar
WHO. Global leprosy strategy 2016–2020. Accelerating towards a leprosy-free world. Operational manual. Geneva: World Health Organization; 2016b.
Google Scholar
Steinmann P, Reed SG, Mirza F, Hollingsworth TD, Richardus JH. Innovative tools and approaches to end the transmission of Mycobacterium leprae. Lancet Infect Dis. 2017;17:e298–305.
Article
PubMed
Google Scholar
WHO. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018.
Google Scholar
Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, Garcia HH, Yang GJ, et al. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis. 2012;6:e1549.
Article
PubMed
PubMed Central
Google Scholar
Osei-Atweneboana MY, Lustigman S, Prichard RK, Boatin BA, Basáñez MG. A research agenda for helminth diseases of humans: health research and capacity building in disease-endemic countries for helminthiases control. PLoS Negl Trop Dis. 2012;6:e1602.
Article
PubMed
PubMed Central
Google Scholar
Boatin BA, Basáñez MG, Prichard RK, Awadzi K, Barakat RM, Garcia HH, et al. A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis. 2012;6:e1547.
Article
PubMed
PubMed Central
Google Scholar
G-Finder. Neglected diseases research and development: uneven progress. Policy Cures Research; 2019.